MARKET

PYPD

PYPD

Polypid Ltd.
NASDAQ
4.210
-0.070
-1.64%
Pre Market: 4.355 +0.145 +3.44% 08:53 03/31 EDT
OPEN
4.340
PREV CLOSE
4.280
HIGH
4.450
LOW
4.200
VOLUME
514
TURNOVER
0
52 WEEK HIGH
5.12
52 WEEK LOW
2.300
MARKET CAP
80.34M
P/E (TTM)
-2.0147
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PYPD last week (0323-0327)?
Weekly Report · 1d ago
PolyPid files initial beneficial ownership statement; COO-US Ori Warshavsky reports 267 ordinary shares owned directly
Reuters · 4d ago
PolyPid files initial beneficial ownership statement; director Nir Dror-Darwish reports 14,440 stock options at $2.67
Reuters · 5d ago
PolyPid Ltd. CFO Jonathan Missulawin files initial beneficial ownership statement
Reuters · 03/23 20:01
PolyPid Director Joseph BenAmram Files Initial Beneficial Ownership Statement
Reuters · 03/23 12:04
Weekly Report: what happened at PYPD last week (0316-0320)?
Weekly Report · 03/23 09:56
Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Axsome Therapeutics (AXSM)
TipRanks · 03/18 20:40
PolyPid Director Brooke Story Files Initial Beneficial Ownership Statement
Reuters · 03/18 20:05
More
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Webull offers Polypid Ltd stock information, including NASDAQ: PYPD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PYPD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PYPD stock methods without spending real money on the virtual paper trading platform.